Verification evidence is still being completed.
PDF / print export
AGC Biologics Denmark
Soborg, Denmark
- Verified lead
- Alberto Santagostino
- Lead status
- STATUS: VERIFIED MARCH 2026
- Leadership verification
- CEO
- 2026 technical specialization
- Biopharmaceutical CDMO, Process Development, Clinical Manufacturing, and Commercial Biologics Production
- Review cycle
- May 2026
- Full address
- Vandtarnsvej 83B, 2860 Soborg, Denmark
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Official AGC Biologics contact page confirming the Soeborg Denmark operating site.
- Editorial note
- AGC Biologics Denmark is published because the official company site confirms both the current chief executive and a real Soeborg biologics manufacturing footprint in Denmark.
Biopharmaceutical CDMO, Process Development, Clinical Manufacturing, and Commercial Biologics Production
Official biologics CDMO profile, Official Denmark site contact disclosure, Corporate leadership disclosure
AGC Biologics Denmark is published because the official company site confirms both the current chief executive and a real Soeborg biologics manufacturing footprint in Denmark.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
AGC Biologics Denmark runs biologics cdmo services, clinical manufacturing, and commercial production in Soborg, Denmark.
- Lead
- Alberto Santagostino (verified ↗)
- Address
- Vandtarnsvej 83B, 2860 Soborg, Denmark (source ↗)
- Compliance
- GMP
- Last reviewed
- 21 Mar 2026 (2mo ago)
- Scale
- Commercial CDMO manufacturing platform
- Capabilities
- Biologics CDMO Services · Clinical Manufacturing · Commercial Production
- Founded
- 2018
- Headcount
- 1001-5000
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED MARCH 2026
Alberto Santagostino
CEO
Full addressVandtarnsvej 83B, 2860 Soborg, Denmark
Site coordinatesVerification evidence is still being completed.
Review cycleMay 2026
Physical site source
Official AGC Biologics contact page listing the Soeborg Denmark site.
Open sourceCommercial CDMO manufacturing platform
Soborg, Denmark. Biopharmaceutical CDMO, Process Development, Clinical Manufacturing, and Commercial Biologics Production. Review completed on 21 Mar 2026.
Danish and international biopharmaceutical manufacturing oversight
Official biologics CDMO profile, Official Denmark site contact disclosure, Corporate leadership disclosure
Biopharmaceutical CDMO, Process Development, Clinical Manufacturing, and Commercial Biologics Production
AGC Biologics Denmark is published because the official company site confirms both the current chief executive and a real Soeborg biologics manufacturing footprint in Denmark.
Editorial note
AGC Biologics Denmark is published because the official company site confirms both the current chief executive and a real Soeborg biologics manufacturing footprint in Denmark.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleMarch 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Biologics CDMO Services
Clinical Manufacturing
Commercial Production
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Biopharmaceutical manufacturing systems
Process-development infrastructure
Commercial production workflow
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
21 Mar 2026: Executive identity confirmed via official management disclosure.
21 Mar 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is AGC Biologics Denmark located?
- AGC Biologics Denmark operates from Vandtarnsvej 83B, 2860 Soborg, Denmark, Soborg, Denmark.
- Who runs AGC Biologics Denmark?
- AGC Biologics Denmark is led by Alberto Santagostino, CEO. Verified 21 Mar 2026.
- What does AGC Biologics Denmark do?
- AGC Biologics Denmark runs biologics cdmo services, clinical manufacturing, and commercial production in Soborg, Denmark. Core capabilities: Biologics CDMO Services, Clinical Manufacturing, Commercial Production.
Editorial context
Related technical briefs
Briefs that name Soborg as a covered market or city.